Gabapentin is available as a generic medication [1].
When did the brand-name gabapentin lose its patent?
The patent for Neurontin, the original brand-name gabapentin, expired, allowing generic versions to enter the market [2]. This patent expiry generally opens the door for competitors to produce and sell their own versions of the drug.
Who makes generic gabapentin?
Several pharmaceutical companies manufacture generic gabapentin. These include major generic drug producers, making the medication widely accessible [1].
How does generic gabapentin differ from brand-name Neurontin?
Generic gabapentin contains the same active ingredient as Neurontin and is therapeutically equivalent. This means it works the same way in the body and has the same safety and efficacy profiles. The primary differences are typically in the inactive ingredients and the cost, with generic versions generally being less expensive [3].
What is gabapentin used for?
Gabapentin is prescribed to treat seizures associated with epilepsy and to relieve nerve pain, particularly neuropathic pain, such as that caused by shingles (postherpetic neuralgia) [4].
What are the potential side effects of gabapentin?
Common side effects of gabapentin can include dizziness, drowsiness, fatigue, and unsteadiness [4]. Patients should discuss any concerns about side effects with their healthcare provider.
Are there any safety concerns with gabapentin?
Like all medications, gabapentin carries potential risks. It is important for patients to take gabapentin exactly as prescribed by their doctor. Information on its safety profile is available from regulatory agencies and prescribing information [4].
Can gabapentin be taken with other medications?
Gabapentin may interact with other drugs. Patients should inform their doctor about all medications they are currently taking to avoid potential interactions [4].
How much does generic gabapentin cost?
The cost of generic gabapentin can vary depending on the pharmacy, dosage, and insurance coverage. However, it is generally significantly more affordable than the brand-name version [1].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050710s031,050711s030,050712s030,050713s026lbl.pdf
[4] https://www.nps.org.au/australian-medicines-australia/gabapentin